Related Experiment Video

Updated: Apr 19, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.3K

Non-small cell lung cancer, version 1.2015

David S Ettinger, Douglas E Wood, Wallace Akerley

    Journal of the National Comprehensive Cancer Network : JNCCN
    |December 16, 2014
    PubMed

    Abstract:

    This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) focuses on the principles of radiation therapy (RT), which include the following: (1) general principles for early-stage, locally advanced, and advanced/metastatic NSCLC; (2) target volumes, prescription doses, and normal tissue dose constraints for early-stage, locally advanced, and advanced/palliative RT; and (3) RT simulation, planning, and delivery. Treatment recommendations should be made by a multidisciplinary team, including board-certified radiation oncologists who perform lung cancer RT as a prominent part of their practice.

    More Related Videos

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
    05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    552

    Related Experiment Videos

    Last Updated: Apr 19, 2026

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
    11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    25.3K
    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
    05:17

    Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

    Published on: October 10, 2025

    552

    Related Concept Videos

    lncRNA - Long Non-coding RNAs02:39

    lncRNA - Long Non-coding RNAs

    10.2K
    In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
    10.2K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.2K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.2K

    Articles linked to this work by shared authors, journal, and citation graph.

    AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.

    Journal for immunotherapy of cancer·2026

    Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026

    Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

    International journal of radiation oncology, biology, physics·2026

    FLASH reduces radiation-induced oral mucositis in a mouse model of Fanconi anemia.

    bioRxiv : the preprint server for biology·2026

    Noninvasive Reversible Software-Based Electron FLASH Irradiation Configuration of a Linear Accelerator in Clinical Use.

    International journal of radiation oncology, biology, physics·2026

    Applying a portable pocket handheld ultrasound scanner to monitor tumor volume in preclinical studies.

    Medical physics·2026

    Comparative Cost-Effectiveness Analysis of First-Line Immunotherapy for Advanced Melanoma Based on 10-Year Clinical Outcomes.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026

    New Paradigms in the Management of Castleman Disease.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026

    Fostering Improvements in Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026

    County-Level Medical Debt and Its Associations With Cancer Stage and Survival in the United States.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026

    Current Surgical Perspectives for Pleural Mesothelioma.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us